{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:44:39Z","timestamp":1793083479393,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32330058"],"award-info":[{"award-number":["32330058"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82361168639"],"award-info":[{"award-number":["82361168639"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32201155"],"award-info":[{"award-number":["32201155"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013152","name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jconrel.2025.114147","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T06:07:22Z","timestamp":1757657242000},"page":"114147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"P2","title":["Vascular endothelial cell-targeted mRNA delivery via synthetic lipid nanoparticles for venous thrombosis prevention"],"prefix":"10.1016","volume":"388","author":[{"given":"Zhiwei","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianfeng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyou","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jconrel.2025.114147_bb0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrcardio.2017.206","article-title":"Current and future antiplatelet therapies: emphasis on preserving haemostasis","volume":"15","author":"McFadyen","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114147_bb0010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41573-020-0061-0","article-title":"Therapeutic strategies for thrombosis: new targets and approaches","volume":"19","author":"Mackman","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10258","key":"10.1016\/j.jconrel.2025.114147_bb0015","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jconrel.2025.114147_bb0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1160\/TH16-08-0615","article-title":"Cancer-associated venous thromboembolism: burden, mechanisms, and management","volume":"117","author":"Ay","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114147_bb0025","first-page":"709","article-title":"Venous thromboembolism in patients with diabetes mellitus","volume":"125","author":"Piazza","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2025.114147_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109216","article-title":"Direct oral anticoagulant prescribing trends for venous thromboembolism among adult patients with obesity at University of Utah Health","volume":"245","author":"Vandenhazel","year":"2025","journal-title":"Thromb. Res."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114147_bb0035","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014539","article-title":"Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement a systematic review and meta-analysis","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/j.jconrel.2025.114147_bb0040","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJMra0801082","article-title":"Mechanisms of thrombus formation","volume":"359","author":"Furie","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114147_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20200145","article-title":"Intelligent antithrombotic nanomedicines: progress, opportunities, and challenges","volume":"2","author":"Xu","year":"2021","journal-title":"View"},{"issue":"8","key":"10.1016\/j.jconrel.2025.114147_bb0050","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/ATVBAHA.108.179655","article-title":"The tissue-type plasminogen activator story","volume":"29","author":"Collen","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jconrel.2025.114147_bb0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0049-3848(90)90379-Q","article-title":"Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells","volume":"10","author":"Rijken","year":"1990","journal-title":"Thromb. Res. Suppl."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114147_bb0060","first-page":"1310","article-title":"Pharmacokinetics and hepatic catabolism of tissue-type plasminogen activator","volume":"41","author":"Tanswell","year":"1991","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jconrel.2025.114147_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113910","article-title":"The nano delivery systems and applications of mRNA","volume":"227","author":"Li","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.114147_bb0070","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13073-017-0450-0","article-title":"Advances in the delivery of RNA therapeutics: from concept to clinical reality","volume":"9","author":"Kaczmarek","year":"2017","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114147_bb0075","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"19","key":"10.1016\/j.jconrel.2025.114147_bb0080","article-title":"A combinatorial library of lipid nanoparticles for cell type-specific mRNA delivery","volume":"10","author":"Naidu","year":"2023","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114147_bb0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/acs.accounts.1c00601","article-title":"Non-liver mRNA Delivery","volume":"55","author":"Loughrey","year":"2022","journal-title":"Acc. Chem. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114147_bb0090","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1038\/s41467-022-32281-5","article-title":"Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo","volume":"13","author":"Ni","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114147_bb0095","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1002\/brx2.7","article-title":"Nucleic acid delivery by ionizable nanocarriers for brain disease treatment","volume":"1","author":"Xiong","year":"2023","journal-title":"Brain-X"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114147_bb0100","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114147_bb0105","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1038\/s41467-023-42948-2","article-title":"Lung SORT LNPs enable precise homology-directed repair mediated CRISPR\/Cas genome correction in cystic fibrosis models","volume":"14","author":"Wei","year":"2023","journal-title":"Nat. Commun."},{"issue":"35","key":"10.1016\/j.jconrel.2025.114147_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202313791","article-title":"Expanding RNAi to kidneys, lungs, and spleen via selective ORgan targeting (SORT) siRNA lipid nanoparticles","volume":"36","author":"Vaidya","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114147_bb0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2016.01.022","article-title":"The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery","volume":"99","author":"Cheng","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114147_bb0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for RNA delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc. Chem. Res."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114147_bb0125","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41551-024-01267-7","article-title":"Optimization of the activity and biodegradability of ionizable lipids for mRNA delivery via directed chemical evolution","volume":"8","author":"Han","year":"2024","journal-title":"Nat. Biomed. Eng."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114147_bb0130","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116271119","article-title":"Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis","volume":"119","author":"Qiu","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114147_bb0135","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1038\/s41598-017-03809-3","article-title":"Tandem malonate-based glucosides (TMGs) for membrane protein structural studies","volume":"7","author":"Hussain","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114147_bb0140","series-title":"Second Supplements to the 2nd Edition of Rodd\u2019s Chemistry of Carbon Compounds","first-page":"375","article-title":"Chapter 5b - natural products containing a cyclohexane, cyclohexene, or cyclohexadiene subunit","author":"Gribble","year":"1991"},{"issue":"8","key":"10.1016\/j.jconrel.2025.114147_bb0145","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1073\/pnas.1620874114","article-title":"Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics","volume":"114","author":"Dahlman","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6661","key":"10.1016\/j.jconrel.2025.114147_bb0150","doi-asserted-by":"crossref","first-page":"eadh5207","DOI":"10.1126\/science.adh5207","article-title":"Intracellular tPA-PAI-1 interaction determines VLDL assembly in hepatocytes","volume":"381","author":"Dai","year":"2023","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114147_bb0155","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41392-024-01871-8","article-title":"Optimized RNA interference therapeutics combined with interleukin-2 mRNA for treating hepatitis B virus infection","volume":"9","author":"Zai","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114147_bb0160","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1038\/s41467-024-50568-7","article-title":"Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin","volume":"15","author":"Jiang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114147_bb0165","first-page":"56697","article-title":"Stenosis of the inferior vena cava: a murine model of deep vein thrombosis","volume":"130","author":"Payne","year":"2017","journal-title":"J. Vis. Exp."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114147_bb0170","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","article-title":"The 60-year evolution of lipid nanoparticles for nucleic acid delivery","volume":"23","author":"Cullis","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114147_bb0175","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1021\/acs.nanolett.2c01133","article-title":"Universal barcoding predicts in vivo ApoE-independent lipid nanoparticle delivery","volume":"22","author":"Da Silva Sanchez","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.114147_bb0180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2020.06.002","article-title":"Lipid nanoparticles for nucleic acid delivery: current perspectives","volume":"154-155","author":"Samaridou","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114147_bb0185","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4161\/rna.8.4.15394","article-title":"Protein expression from exogenous mRNA: uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway","volume":"8","author":"Lorenz","year":"2011","journal-title":"RNA Biol."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114147_bb0190","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","article-title":"Venous thromboembolism in cancer patients: ESMO clinical practice guideline","volume":"34","author":"Falanga","year":"2023","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114147_bb0195","first-page":"233","article-title":"Regulation of endothelial cell t-PA synthesis and release","volume":"59","author":"Kooistra","year":"1994","journal-title":"Int. J. Hematol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114147_bb0200","first-page":"198","article-title":"Tissue-type plasminogen activator","volume":"45","author":"Lijnen","year":"1987","journal-title":"Ann. Biol. Clin (Paris)."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114147_bb0205","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1182\/blood-2010-05-287623","article-title":"von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models","volume":"117","author":"Brill","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114147_bb0210","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41573-023-00859-3","article-title":"Strategies to reduce the risks of mRNA drug and vaccine toxicity","volume":"23","author":"Bitounis","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114147_bb0215","first-page":"379","article-title":"The prophylaxis against venous thromboembolic complications in internal medicine--the gap between theory and practice","volume":"52","author":"Hirmerov\u00e1","year":"2006","journal-title":"Vnitr. Lek."},{"key":"10.1016\/j.jconrel.2025.114147_bb0220","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2023.01.036","article-title":"Cytosolic perfluorocarbon delivery to platelets via albumin for antithrombotic therapy","volume":"355","author":"Luo","year":"2023","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114147_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201905145","article-title":"Engineered Nanoplatelets for targeted delivery of plasminogen activators to reverse Thrombus in multiple mouse thrombosis models","volume":"32","author":"Xu","year":"2020","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114147_bb0230","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1182\/blood.V71.6.1641.1641","article-title":"Preparation of polyethylene glycol-tissue plasminogen activator adducts that retain functional activity: characteristics and behavior in three animal species","volume":"71","author":"Berger","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2025.114147_bb0235","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2013.12.036","article-title":"Bio-responsive delivery of tissue plasminogen activator for localized thrombolysis","volume":"177","author":"Absar","year":"2014","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114147_bb0240","first-page":"233","article-title":"Recent strategies on targeted delivery of thrombolytics","volume":"14","author":"Huang","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"issue":"19","key":"10.1016\/j.jconrel.2025.114147_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202201265","article-title":"A fibrinogen-mimicking, activated-platelet-sensitive Nanocoacervate enhances Thrombus targeting and penetration of tissue plasminogen activator for effective thrombolytic therapy","volume":"11","author":"Huang","year":"2022","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114147_bb0250","first-page":"9","article-title":"Ionizable drug delivery systems for efficient and selective gene therapy","volume":"10","author":"Zhang","year":"2023","journal-title":"Mil. Med. Res."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114147_bb0255","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/nat.2018.0734","article-title":"MicroRNAs enable mRNA therapeutics to selectively program Cancer cells to self-destruct","volume":"28","author":"Jain","year":"2018","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.jconrel.2025.114147_bb0260","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jconrel.2024.10.028","article-title":"Paracyclophane-based ionizable lipids for efficient mRNA delivery in vivo","volume":"376","author":"Wu","year":"2024","journal-title":"J. Control. Release"},{"issue":"22","key":"10.1016\/j.jconrel.2025.114147_bb0265","doi-asserted-by":"crossref","first-page":"15085","DOI":"10.1021\/jacs.4c00451","article-title":"Multicomponent synthesis of imidazole-based Ionizable lipids for highly efficient and spleen-selective messenger RNA delivery","volume":"146","author":"Dong","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114147_bb0270","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/nat.2017.0716","article-title":"Current challenges in delivery and cytosolic translocation of therapeutic RNAs","volume":"28","author":"Johannes","year":"2018","journal-title":"Nucleic Acid Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114147_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10213","article-title":"Cytosolic delivery of nucleic acids: the case of ionizable lipid nanoparticles","volume":"6","author":"Schlich","year":"2021","journal-title":"Bioeng. Transl. Med."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114147_bb0280","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1021\/acs.bioconjchem.0c00366","article-title":"The biomolecular Corona of lipid nanoparticles for gene therapy","volume":"31","author":"Francia","year":"2020","journal-title":"Bioconjug. Chem."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114147_bb0285","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.ymthe.2022.04.011","article-title":"Pro-inflammatory concerns with lipid nanoparticles","volume":"30","author":"Moghimi","year":"2022","journal-title":"Mol. Ther."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925007588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925007588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T08:53:08Z","timestamp":1780822388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925007588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"alternative-id":["S0168365925007588"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114147","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular endothelial cell-targeted mRNA delivery via synthetic lipid nanoparticles for venous thrombosis prevention","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114147"}}